| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 107.980 | 288.760 | 422.035 | 361.192 | 298.764 | 305.304 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 107.779 | 289.392 | 422.037 | 372.822 | 298.765 | 317.473 |
| Total Expenses - EUR | 28 | 0 | 1.999 | 1.474 | 96.588 | 232.378 | 313.363 | 251.492 | 224.466 | 315.012 |
| Gross Profit/Loss - EUR | -28 | 0 | -1.999 | -1.474 | 11.191 | 57.014 | 108.673 | 121.330 | 74.299 | 2.461 |
| Net Profit/Loss - EUR | -28 | 0 | -1.999 | -1.474 | 10.114 | 54.321 | 104.791 | 117.718 | 71.760 | -5.920 |
| Employees | 0 | 0 | 1 | 1 | 6 | 6 | 10 | 10 | 8 | 8 |
Check the financial reports for the company - Clipperton Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 21.221 | 18.253 | 15.186 | 34.657 | 32.358 | 28.407 |
| Current Assets | 3 | 30 | 4 | 94 | 12.776 | 62.982 | 120.701 | 118.716 | 90.161 | 67.983 |
| Inventories | 0 | 0 | 0 | 0 | 73 | 1.263 | 1.496 | 0 | 1.861 | 434 |
| Receivables | 0 | 0 | 0 | 0 | 12.452 | 46.889 | 97.448 | 114.418 | 74.657 | 55.762 |
| Cash | 3 | 30 | 4 | 94 | 251 | 14.829 | 21.757 | 4.298 | 13.643 | 11.787 |
| Shareholders Funds | -2.279 | -2.234 | -4.195 | -5.538 | 4.683 | 54.490 | 104.956 | 118.222 | 86.783 | 33.900 |
| Social Capital | 45 | 45 | 44 | 97 | 95 | 93 | 91 | 91 | 91 | 90 |
| Debts | 2.282 | 2.264 | 4.199 | 5.632 | 29.314 | 26.745 | 30.932 | 35.152 | 35.736 | 62.490 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Clipperton Medical Srl